查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1671178

皮膚科治療藥的全球市場:市場規模·佔有率·趨勢，產業分析 (不同治療·各類型·各給藥途徑·各流通管道·各類藥物·各地區)，未來預測 (2025年～2034年)

Dermatology Drugs Market Size, Share, Trends, Industry Analysis Report: By Therapy, Type, Route of Administration, Distribution Channel, Drug Class, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 119 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的一項新研究，皮膚病藥物市場預計到 2034 年將達到 661.5 億美元。該報告提供了有關當前市場動態的詳細見解，並對未來市場的成長進行了分析。

皮膚病藥物市場的成長主要得益於痤瘡、牛皮癬、濕疹和皮膚癌等皮膚病的發病率不斷上升以及治療方案的進步。主要驅動因素包括對生物製劑和標靶治療的需求不斷增長，特別是針對慢性和嚴重皮膚病，以及人們對皮膚健康的認識不斷提高。由於非處方藥（OTC）的擴張和使用基因檢測進行個人化皮膚病治療的日益增加，皮膚病藥物的市場機會存在。

美容皮膚病治療的興起、外用藥物配方的創新以及為提高患者參與度而整合的數位健康解決方案等趨勢正在塑造市場。隨著此類先進治療方法的不斷普及以及新興市場醫療保健管道的不斷拓寬，皮膚病藥物市場預計將繼續成長。

皮膚病治療市場：分析概述

根據治療，痤瘡治療部分佔皮膚病藥物市場收入的最大份額。這是因為痤瘡發病率很高，尤其是在青少年和年輕人中，並且外用和口服治療的廣泛使用。牛皮癬也是一個重要的細分領域，生物製劑和標靶療法的採用推動了強勁成長。

處方藥在皮膚科藥物市場中佔據主導地位，因為牛皮癬和濕疹等慢性皮膚病需要專門治療。隨著越來越多的消費者青睞便利且經濟高效的自我保健選擇，非處方（OTC）藥品產業正在迅速成長。

依給藥途徑劃分，外用藥物佔比最大，是多種皮膚病的第一線治療方法。口服藥物領域成長最快，尤其是由於推出了新的口服生物製劑和針對痤瘡和牛皮癬等疾病的系統治療方法。

根據分銷管道，醫院藥房部分佔據最大的市場份額，主要是由於對嚴重皮膚病的專門治療的需求。由於非處方皮膚病產品的需求不斷增加以及消費者獲得這些治療的機會不斷擴大，零售藥局領域是成長最快的領域。

北美憑藉其先進的醫療保健體系、較高的皮膚病學認知度以及製藥公司的強大市場影響力，佔據了全球皮膚病藥物市場的主導地位。亞太地區是成長最快的地區，其推動力是醫療保健機會的增加、認識的提高以及對皮膚病治療的需求不斷增長。

皮膚病治療市場的主要參與者包括艾伯維、Elilily·與·公司，強生，諾華，GlaxoSmithKline Plc，amujen，輝瑞，Sanofi，拜耳，默克·與·公司，UCB，布里斯托爾·maiyazusukuibu，歐萊雅，garuderuma，meda·famashutikaruzu等。

目錄

第1章 簡介

第2章 摘要整理

第3章 分析方法

第4章 全球皮膚科治療藥市場洞察

  • 市場概述
  • 皮膚科治療藥的市場動態
    • 促進因素和機會
      • 皮膚病學對生物製品的需求不斷增加
      • 外用藥物和非處方 (OTC) 藥物的轉變
    • 阻礙因素和挑戰
      • 護膚藥物成本高
  • 大環境分析
  • 皮膚科治療藥市場趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 全球皮膚科治療藥市場:不同治療

  • 主要的分析結果
  • 簡介
  • 痤瘡
  • 乾癬
  • 酒糟先生皮膚炎
  • 脫髮症
  • 其他

第6章 全球皮膚科治療藥市場:各類型

  • 主要的分析結果
  • 處方箋
  • 店面銷售(OTC)

第7章 全球皮膚科治療藥市場:各給藥途徑

  • 主要的分析結果
  • 簡介
  • 局部
  • 口服
  • 非口服

第8章 全球皮膚科治療藥市場:各流通管道

  • 主要的分析結果
  • 簡介
  • 醫院藥局
  • 零售藥局
  • 其他

第9章 全球皮膚科治療藥市場:各類藥物

  • 主要的分析結果
  • 簡介
  • 抗感染藥物
  • 皮質類固醇
  • 預防痤瘡
  • 鈣調磷酸酶抑制劑
  • 類視黃酸
  • 其他

第10章 全球皮膚科治療藥市場:各地區

  • 主要的分析結果
  • 簡介
    • 皮膚科治療藥市場評估:各地區 (2020～2034年)
  • 北美
    • 北美:不同治療 (2020～2034年)
    • 北美:各類型 (2020～2034年)
    • 北美:各給藥途徑 (2020～2034年)
    • 北美:各流通管道 (2020～2034年)
    • 北美:各類藥物 (2020～2034年)
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:不同治療 (2020～2034年)
    • 歐洲:各類型 (2020～2034年)
    • 歐洲:各給藥途徑 (2020～2034年)
    • 歐洲:各流通管道 (2020～2034年)
    • 歐洲:各類藥物 (2020～2034年)
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:不同治療 (2020～2034年)
    • 亞太地區:各類型 (2020～2034年)
    • 亞太地區:各給藥途徑 (2020～2034年)
    • 亞太地區:各流通管道 (2020～2034年)
    • 亞太地區:各類藥物 (2020～2034年)
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:不同治療 (2020～2034年)
    • 中東·非洲:各類型 (2020～2034年)
    • 中東·非洲:各給藥途徑 (2020～2034年)
    • 中東·非洲:各流通管道 (2020～2034年)
    • 中東·非洲:各類藥物 (2020～2034年)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東·非洲
  • 南美
    • 南美:不同治療 (2020～2034年)
    • 南美:各類型 (2020～2034年)
    • 南美:各給藥途徑 (2020～2034年)
    • 南美:各流通管道 (2020～2034年)
    • 南美:各類藥物 (2020～2034年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第11章 競爭情形

  • 事業擴大·企業收購的分析
    • 事業擴大
    • 企業收購
  • 聯盟/合作/協定/公開

第12章 企業簡介

  • AbbVie
  • Amgen
  • Bayer
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Galderma
  • GlaxoSmithKline
  • Johnson & Johnson
  • L'Oreal
  • Meda Pharmaceuticals
Product Code: PM1106

The dermatology drugs market size is expected to reach USD 66.15 billion by 2034, according to a new study by Polaris Market Research. The report "Dermatology Drugs Market Size, Share, Trends, Industry Analysis Report: By Therapy (Acne, Psoriasis, Rosacea, Alopecia, and Others), Type, Route of Administration, Distribution Channel, Drug Class, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The dermatology drugs market growth is significantly driven by an increasing prevalence of skin conditions, such as acne, psoriasis, eczema, and skin cancer, coupled with advancements in treatment options. Key drivers include the rising demand for biologics and targeted therapies, particularly for chronic and severe skin diseases, as well as the growing awareness about skin health. Dermatology drugs market opportunities exist in the expansion of over-the-counter (OTC) products and the increasing shift toward personalized dermatology treatments, leveraging genetic testing for more tailored care.

Trends such as the rise in aesthetic dermatology treatments, innovations in topical drug formulations, and the integration of digital health solutions for improved patient engagement are shaping the market. With the growing adoption of these advanced treatments and increasing healthcare access in emerging markets, the dermatology drugs market is poised for continued growth.

Dermatology Drugs Market Report Highlights:

Based on therapy, the acne therapy segment holds the largest share of the dermatology drugs market revenue due to the high prevalence of acne, especially among teens and young adults, and the widespread use of topical and oral treatments. Psoriasis is also a significant segment, with strong growth driven by the adoption of biologics and targeted therapies.

The prescription drugs segment, by type, dominates the dermatology drugs market share due to the need for specialized treatments for chronic skin conditions, such as psoriasis and eczema. The over-the-counter (OTC) segment is growing rapidly, driven by increasing consumer preference for accessible, cost-effective self-care solutions.

In terms of route of administration, the topical segment holds the largest share, as it is the first-line treatment for many skin conditions. The oral segment is registering the highest growth, especially with the introduction of new oral biologics and systemic treatments for conditions such as acne and psoriasis.

The hospital pharmacies segment, by distribution channel, holds the largest market share, primarily due to the demand for specialized treatments for severe dermatological conditions. The retail pharmacies segment is the fastest-growing segment, driven by the increasing demand for OTC dermatology products and greater consumer access to these treatments.

North America dominates the global dermatology drugs market share due to advanced healthcare systems, high dermatology awareness, and strong market presence of pharmaceutical companies. Asia Pacific is the fastest-growing region, driven by increasing healthcare access, rising awareness, and growing demand for dermatology treatments.

A few key players in the dermatology drugs market are AbbVie, Eli Lilly and Company, Johnson & Johnson, Novartis, GlaxoSmithKline, Amgen, Pfizer, Sanofi, Bayer, Merck & Co., UCB, Bristol-Myers Squibb, L'Oreal, Galderma, and Meda Pharmaceuticals.

Polaris Market Research has segmented the dermatology drugs market report on the basis of therapy, type, route of administration, distribution channel, drug class, and region:

By Therapy Outlook (Revenue - USD Billion, 2020-2034)

  • Acne
  • Psoriasis
  • Rosacea
  • Alopecia
  • Others

By Type Outlook (Revenue - USD Billion, 2020-2034)

  • Prescription
  • Over-the-Counter (OTC)

By Route of Administration Outlook (Revenue - USD Billion, 2020-2034)

  • Topical
  • Oral
  • Parenteral

By Distribution Channel Outlook (Revenue - USD Billion, 2020-2034)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

By Drug Class Outlook (Revenue - USD Billion, 2020-2034)

  • Anti-Infectives
  • Corticosteroids
  • Anti-Acne
  • Calcineurin Inhibitors
  • Retinoids
  • Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Dermatology Drugs Market Insights

  • 4.1. Dermatology Drugs Market - Frequency Snapshot
  • 4.2. Dermatology Drugs Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing Demand for Biologics in Dermatology
      • 4.2.1.2. Shift Toward Topical Treatments and Over-the-Counter (OTC) Products
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Dermatology Drugs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Dermatology Drugs Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Dermatology Drugs Market, by Therapy

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • 5.3. Acne
    • 5.3.1. Global Dermatology Drugs Market, Acne, by Region, 2020-2034 (USD Billion)
  • 5.4. Psoriasis
    • 5.4.1. Global Dermatology Drugs Market, by Psoriasis, by Region, 2020-2034 (USD Billion)
  • 5.5. Rosacea
    • 5.5.1. Global Dermatology Drugs Market, by Rosacea, by Region, 2020-2034 (USD Billion)
  • 5.6. Alopecia
    • 5.6.1. Global Dermatology Drugs Market, by Alopecia, by Region, 2020-2034 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Dermatology Drugs Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Dermatology Drugs Market, by Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • 6.3. Prescription
    • 6.3.1. Global Dermatology Drugs Market, by Prescription, by Region, 2020-2034 (USD Billion)
  • 6.4. Over-the-Counter (OTC)
    • 6.4.1. Global Dermatology Drugs Market, by Over-the-Counter (OTC), by Region, 2020-2034 (USD Billion)

7. Global Dermatology Drugs Market, by Route of Administration

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • 7.3. Topical
    • 7.3.1. Global Dermatology Drugs Market, by Topical, by Region, 2020-2034 (USD Billion)
  • 7.4. Oral
    • 7.4.1. Global Dermatology Drugs Market, Oral, by Region, 2020-2034 (USD Billion)
  • 7.5. Parenteral
    • 7.5.1. Global Dermatology Drugs Market, Parenteral, by Region, 2020-2034 (USD Billion)

8. Global Dermatology Drugs Market, by Distribution Channel

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.3. Hospital Pharmacies
    • 8.3.1. Global Dermatology Drugs Market, by Hospital Pharmacies, by Region, 2020-2034 (USD Billion)
  • 8.4. Retail Pharmacies
    • 8.4.1. Global Dermatology Drugs Market, by Retail Pharmacies, by Region, 2020-2034 (USD Billion)
  • 8.5. Others
    • 8.5.1. Global Dermatology Drugs Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Dermatology Drugs Market, by Drug Class

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • 9.3. Anti-Infectives
    • 9.3.1. Global Dermatology Drugs Market, by Anti-Infectives, by Region, 2020-2034 (USD Billion)
  • 9.4. Corticosteroids
    • 9.4.1. Global Dermatology Drugs Market, by Corticosteroids, by Region, 2020-2034 (USD Billion)
  • 9.5. Anti-Acne
    • 9.5.1. Global Dermatology Drugs Market, by Anti-Acne, by Region, 2020-2034 (USD Billion)
  • 9.6. Calcineurin Inhibitors
    • 9.6.1. Global Dermatology Drugs Market, by Calcineurin Inhibitors, by Region, 2020-2034 (USD Billion)
  • 9.7. Retinoids
    • 9.7.1. Global Dermatology Drugs Market, by Retinoids, by Region, 2020-2034 (USD Billion)
  • 9.8. Others
    • 9.8.1. Global Dermatology Drugs Market, by Others, by Region, 2020-2034 (USD Billion)

10. Global Dermatology Drugs Market, by Geography

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Dermatology Drugs Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 10.3. Dermatology Drugs Market - North America
    • 10.3.1. North America: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
    • 10.3.2. North America: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
    • 10.3.3. North America: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.3.4. North America: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.3.5. North America: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.3.7. Dermatology Drugs Market - U.S.
      • 10.3.7.1. U.S.: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.3.7.2. U.S.: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.3.7.3. U.S.: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.3.7.4. U.S.: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.3.7.5. U.S.: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.3.8. Dermatology Drugs Market - Canada
      • 10.3.8.1. Canada: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.3.8.2. Canada: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.3.8.3. Canada: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.3.8.4. Canada: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.3.8.5. Canada: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • 10.4. Dermatology Drugs Market - Europe
    • 10.4.1. Europe: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
    • 10.4.2. Europe: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
    • 10.4.3. Europe: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.4.4. Europe: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.4.5. Europe: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.4.6. Dermatology Drugs Market - UK
      • 10.4.6.1. UK: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.6.2. UK: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.4.6.3. UK: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.6.4. UK: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.4.6.5. UK: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.4.7. Dermatology Drugs Market - France
      • 10.4.7.1. France: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.7.2. France: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.4.7.3. France: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.7.4. France: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.4.7.5. France: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.4.8. Dermatology Drugs Market - Germany
      • 10.4.8.1. Germany: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.8.2. Germany: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.4.8.3. Germany: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.8.4. Germany: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.4.8.5. Germany: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.4.9. Dermatology Drugs Market - Italy
      • 10.4.9.1. Italy: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.9.2. Italy: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.4.9.3. Italy: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.9.4. Italy: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.4.9.5. Italy: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.4.10. Dermatology Drugs Market - Spain
      • 10.4.10.1. Spain: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.10.2. Spain: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.4.10.3. Spain: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.10.4. Spain: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.4.10.5. Spain: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.4.11. Dermatology Drugs Market - Netherlands
      • 10.4.11.1. Netherlands: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.11.2. Netherlands: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.4.11.3. Netherlands: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.11.4. Netherlands: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.4.11.5. Netherlands: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.4.12. Dermatology Drugs Market - Russia
      • 10.4.12.1. Russia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.12.2. Russia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.4.12.3. Russia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.12.4. Russia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.4.12.5. Russia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.4.13. Dermatology Drugs Market - Rest of Europe
      • 10.4.13.1. Rest of Europe: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.13.2. Rest of Europe: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.4.13.3. Rest of Europe: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.13.4. Rest of Europe: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.4.13.5. Rest of Europe: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • 10.5. Dermatology Drugs Market - Asia Pacific
    • 10.5.1. Asia Pacific: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
    • 10.5.2. Asia Pacific: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
    • 10.5.3. Asia Pacific: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.5.4. Asia Pacific: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.5.5. Asia Pacific: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.5.6. Dermatology Drugs Market - China
      • 10.5.6.1. China: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.6.2. China: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.5.6.3. China: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.6.4. China: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.5.6.5. China: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.5.7. Dermatology Drugs Market - India
      • 10.5.7.1. India: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.7.2. India: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.5.7.3. India: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.7.4. India: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.5.7.5. India: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.5.8. Dermatology Drugs Market - Malaysia
      • 10.5.8.1. Malaysia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.8.2. Malaysia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.5.8.3. Malaysia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.8.4. Malaysia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.5.8.5. Malaysia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.5.9. Dermatology Drugs Market - Japan
      • 10.5.9.1. Japan: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.9.2. Japan: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.5.9.3. Japan: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.9.4. Japan: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.5.9.5. Japan: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.5.10. Dermatology Drugs Market - Indonesia
      • 10.5.10.1. Indonesia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.10.2. Indonesia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.5.10.3. Indonesia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.10.4. Indonesia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.5.10.5. Indonesia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.5.11. Dermatology Drugs Market - South Korea
      • 10.5.11.1. South Korea: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.11.2. South Korea: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.5.11.3. South Korea: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.11.4. South Korea: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.5.11.5. South Korea: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.5.12. Dermatology Drugs Market - Australia
      • 10.5.12.1. Australia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.12.2. Australia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.5.12.3. Australia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.12.4. Australia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.5.12.5. Australia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.5.13. Dermatology Drugs Market - Rest of Asia Pacific
      • 10.5.13.1. Rest of Asia Pacific: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.13.2. Rest of Asia Pacific: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.5.13.3. Rest of Asia Pacific: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.13.4. Rest of Asia Pacific: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.5.13.5. Rest of Asia Pacific: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • 10.6. Dermatology Drugs Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
    • 10.6.2. Middle East & Africa: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
    • 10.6.3. Middle East & Africa: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.6.4. Middle East & Africa: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.6.5. Middle East & Africa: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.6.6. Dermatology Drugs Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.6.6.2. Saudi Arabia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.6.7. Dermatology Drugs Market - UAE
      • 10.6.7.1. UAE: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.6.7.2. UAE: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.6.7.3. UAE: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.7.4. UAE: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.6.7.5. UAE: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.6.8. Dermatology Drugs Market - Israel
      • 10.6.8.1. Israel: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.6.8.2. Israel: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.6.8.3. Israel: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.8.4. Israel: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.6.8.5. Israel: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.6.9. Dermatology Drugs Market - South Africa
      • 10.6.9.1. South Africa: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.6.9.2. South Africa: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.6.9.3. South Africa: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.9.4. South Africa: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.6.9.5. South Africa: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.6.10. Dermatology Drugs Market - Rest of Middle East & Africa
      • 10.6.10.1. Rest of Middle East & Africa: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.6.10.2. Rest of Middle East & Africa: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.6.10.3. Rest of Middle East & Africa: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.10.4. Rest of Middle East & Africa: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.6.10.5. Rest of Middle East & Africa: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • 10.7. Dermatology Drugs Market - Latin America
    • 10.7.1. Latin America: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
    • 10.7.2. Latin America: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
    • 10.7.3. Latin America: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.7.4. Latin America: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.7.5. Latin America: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.7.6. Dermatology Drugs Market - Mexico
      • 10.7.6.1. Mexico: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.7.6.2. Mexico: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.7.6.3. Mexico: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.7.6.4. Mexico: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.7.6.5. Mexico: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.7.7. Dermatology Drugs Market - Brazil
      • 10.7.7.1. Brazil: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.7.7.2. Brazil: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.7.7.3. Brazil: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.7.7.4. Brazil: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.7.7.5. Brazil: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.7.8. Dermatology Drugs Market - Argentina
      • 10.7.8.1. Argentina: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.7.8.2. Argentina: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.7.8.3. Argentina: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.7.8.4. Argentina: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.7.8.5. Argentina: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.7.9. Dermatology Drugs Market - Rest of Latin America
      • 10.7.9.1. Rest of Latin America: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.7.9.2. Rest of Latin America: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.7.9.3. Rest of Latin America: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.7.9.4. Rest of Latin America: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.7.9.5. Rest of Latin America: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. AbbVie
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Amgen
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Bayer
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. Bristol-Myers Squibb
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Eli Lilly and Company
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Galderma
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. GlaxoSmithKline
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Johnson & Johnson
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. L'Oreal
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Meda Pharmaceuticals
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development

List of Tables:

  • Table 1 Global Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 2 Global Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 3 Global Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 4 Global Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 5 Global Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 6 North America: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 7 North America: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 8 North America: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 9 North America: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 10 North America: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 11 U.S.: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 12 U.S.: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 13 U.S.: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 14 U.S.: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 15 U.S.: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 16 Canada: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 17 Canada: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 18 Canada: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 19 Canada: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 20 Canada: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 21 Europe: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 22 Europe: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 23 Europe: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 24 Europe: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 25 Europe: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 26 UK: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 27 UK: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 28 UK: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 29 UK: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 30 UK: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 31 France: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 32 France: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 33 France: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 34 France: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 35 France: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 36 Germany: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 37 Germany: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 38 Germany: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 39 Germany: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 40 Germany: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 41 Italy: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 42 Italy: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 43 Italy: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 44 Italy: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 45 Italy: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 46 Spain: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 47 Spain: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 48 Spain: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 49 Spain: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 50 Spain: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 51 Netherlands: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 52 Netherlands: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 53 Netherlands: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 54 Netherlands: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 55 Netherlands: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 56 Russia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 57 Russia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 58 Russia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 59 Russia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 60 Russia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 61 Rest of Europe: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 62 Rest of Europe: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 63 Rest of Europe: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 64 Rest of Europe: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 65 Rest of Europe: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 66 Asia Pacific: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 67 Asia Pacific: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 68 Asia Pacific: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 69 Asia Pacific: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 70 Asia Pacific: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 71 China: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 72 China: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 73 China: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 74 China: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 75 China: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 76 India: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 77 India: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 78 India: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 79 India: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 80 India: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 81 Malaysia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 82 Malaysia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 83 Malaysia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 84 Malaysia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 85 Malaysia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 86 Japan: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 87 Japan: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 88 Japan: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 89 Japan: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 90 Japan: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 91 Indonesia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 92 Indonesia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 93 Indonesia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 94 Indonesia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 95 Indonesia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 96 South Korea: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 97 South Korea: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 98 South Korea: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 99 South Korea: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 100 South Korea: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 101 Australia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 102 Australia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 103 Australia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 104 Australia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 105 Australia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 106 Rest of Asia Pacific: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 107 Rest of Asia Pacific: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 108 Rest of Asia Pacific: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 109 Rest of Asia Pacific: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 110 Rest of Asia Pacific: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 111 Middle East & Africa: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 112 Middle East & Africa: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 113 Middle East & Africa: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 114 Middle East & Africa: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 115 Middle East & Africa: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 116 Saudi Arabia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 117 Saudi Arabia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 118 Saudi Arabia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 119 Saudi Arabia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 120 Saudi Arabia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 121 UAE: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 122 UAE: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 123 UAE: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 124 UAE: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 125 UAE: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 126 Israel: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 127 Israel: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 128 Israel: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 129 Israel: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 130 Israel: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 131 South Africa: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 132 South Africa: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 133 South Africa: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 134 South Africa: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 135 South Africa: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 136 Rest of Middle East & Africa: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 137 Rest of Middle East & Africa: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 138 Rest of Middle East & Africa: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 139 Rest of Middle East & Africa: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 140 Rest of Middle East & Africa: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 141 Latin America: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 142 Latin America: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 143 Latin America: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 144 Latin America: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 145 Latin America: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 146 Mexico: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 147 Mexico: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 148 Mexico: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 149 Mexico: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 150 Mexico: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 151 Brazil: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 152 Brazil: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 153 Brazil: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 154 Brazil: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 155 Brazil: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 156 Argentina: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 157 Argentina: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 158 Argentina: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 159 Argentina: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 160 Argentina: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 161 Rest of Latin America: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 162 Rest of Latin America: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 163 Rest of Latin America: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 164 Rest of Latin America: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 165 Rest of Latin America: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Dermatology Drugs Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Therapy
  • Figure 7. Global Dermatology Drugs Market, by Therapy, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Type
  • Figure 9. Global Dermatology Drugs Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Route of Administration
  • Figure 11. Global Dermatology Drugs Market, by Route of Administration, 2024 & 2034 (USD Billion)
  • Figure 12. Market by Distribution Channel
  • Figure 13. Global Dermatology Drugs Market, by Distribution Channel, 2024 & 2034 (USD Billion)
  • Figure 14. Market by Drug Class
  • Figure 15. Global Dermatology Drugs Market, by Drug Class, 2024 & 2034 (USD Billion)